Literature DB >> 24043975

Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.

Christoph Niessen1, Ernst Michael Jung, Walter A Wohlgemuth, Benedikt Trabold, Michael Haimerl, Andreas Schreyer, Christian Stroszczynski, Philipp Wiggermann.   

Abstract

We report in a 65-year-old man hepatocellular carcinoma adjacent to a transjugular intrahepatic portosystemic shunt stent-graft which was successfully treated with irreversible electroporation (IRE). IRE is a new non-thermal tissue ablation technique which uses electrical pulses to induce cell necrosis by irreversible membrane poration. IRE proved to be more advantageous in the ablation of perivascular tumor with little injury to the surrounding structures.

Entities:  

Keywords:  Carcinoma, hepatocellular; Catheter Ablation, radiofrequency; Irreversible electroporation; Liver neoplasms; Radiology, interventional

Mesh:

Year:  2013        PMID: 24043975      PMCID: PMC3772261          DOI: 10.3348/kjr.2013.14.5.797

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  13 in total

1.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

2.  Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation.

Authors:  Edward W Lee; Christopher T Loh; Stephen T Kee
Journal:  Technol Cancer Res Treat       Date:  2007-08

3.  Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size.

Authors:  E J Patterson; C H Scudamore; D A Owen; A G Nagy; A K Buczkowski
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

4.  Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization.

Authors:  Ajita Deodhar; Timm Dickfeld; Gordon W Single; William C Hamilton; Raymond H Thornton; Constantinos T Sofocleous; Majid Maybody; Mithat Gónen; Boris Rubinsky; Stephen B Solomon
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

5.  Ablation of perivascular hepatic malignant tumors with irreversible electroporation.

Authors:  T Peter Kingham; Ami M Karkar; Michael I D'Angelica; Peter J Allen; Ronald P Dematteo; George I Getrajdman; Constantinos T Sofocleous; Stephen B Solomon; William R Jarnagin; Yuman Fong
Journal:  J Am Coll Surg       Date:  2012-06-16       Impact factor: 6.113

6.  Irreversible electroporation in a Swine lung model.

Authors:  Damian E Dupuy; Bassam Aswad; Thomas Ng
Journal:  Cardiovasc Intervent Radiol       Date:  2010-12-30       Impact factor: 2.740

7.  Minimizing diaphragmatic injury during radio-frequency ablation: efficacy of subphrenic peritoneal saline injection in a porcine model.

Authors:  Steven S Raman; David S K Lu; Darko J Vodopich; James Sayre; Charles Lassman
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

Review 8.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

Authors:  Yun Ku Cho; Jae Kyun Kim; Mi Young Kim; Hyunchul Rhim; Joon Koo Han
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

9.  Radiofrequency ablation for treating liver metastases from a non-colorectal origin.

Authors:  Bo La Yun; Jeong Min Lee; Ji Hyun Baek; Se Hyung Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2011-08-24       Impact factor: 3.500

10.  Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  Nam Kyu Chang; Sang Soo Shin; Jin Woong Kim; Hyung Jun Kim; Yong Yeon Jeong; Suk Hee Heo; Jae Kyu Kim; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2012-04-23       Impact factor: 3.500

View more
  6 in total

1.  Preclinical and clinical evaluation of the liver tumor irreversible electroporation by magnetic resonance imaging.

Authors:  Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Daniele Procissi; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  The interaction between irreversible electroporation therapy (IRE) and embolization material using a validated vegetal model: an experimental study.

Authors:  Philip Chan; Catriona McLean; Stephen Chan; Gerard S Goh
Journal:  Diagn Interv Radiol       Date:  2019-07       Impact factor: 2.630

Review 3.  Hepatocellular Carcinoma: The Role of Interventional Oncology.

Authors:  Matteo Donadon; Luigi Solbiati; Laura Dawson; Aisling Barry; Gonzalo Sapisochin; Paul D Greig; Shuichiro Shiina; Andrea Fontana; Guido Torzilli
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

4.  Bursts of Bipolar Microsecond Pulses Inhibit Tumor Growth.

Authors:  Michael B Sano; Christopher B Arena; Katelyn R Bittleman; Matthew R DeWitt; Hyung J Cho; Christopher S Szot; Dieter Saur; James M Cissell; John Robertson; Yong W Lee; Rafael V Davalos
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

5.  Re: irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.

Authors:  Uei Pua
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

6.  Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.

Authors:  Jonas Scheck; Philipp Bruners; David Schindler; Christiane Kuhl; Peter Isfort
Journal:  Korean J Radiol       Date:  2018-06-14       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.